Evidence map›Paper›PMID 31418054›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2020

Laure Michaud, B J Beattie, T Akhurst, M Dunphy, P Zanzonico, R Finn, A Mauguen, H Schöder, W A Weber, A B Lassman and 1 more

Erratum issued 2 registry-linked trialsOpen access · hybridAbstract read
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to 2 registered trials, which are not on this map. Cited by 34 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 3 pooled it
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05553041 early_phase1recruitingnot on this mapstarted 2024, after this paper: background citation

Evaluation of 18F-Fluciclovine PET-MRI to Differentiate Tumor Progression From Post-treatment Changes in Pediatric High-grade Glioma (HGG)

TypeinterventionalSponsorChildren's Hospital of PhiladelphiaRan2024 to 2027Enrolled30ConditionsGlioma, High Grade Glioma, Glioma, Malignant, Glioma IntracranialArms18F-Fluciclovine PET-MRI
NCT05555550 early_phase1recruitingnot on this mapstarted 2026, after this paper: background citation

Evaluation of 18F-Fluciclovine PET-MRI as a Biomarker of Response in Pediatric and Young Adult Patients With Low Grade Gliomas (LGG)

TypeinterventionalSponsorChildren's Hospital of PhiladelphiaRan2026 to 2027Enrolled30ConditionsGlioma, Low-grade Glioma, Low Grade Glioma of Brain, Glioma, MalignantArms18F-Fluciclovine
3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 3 syntheses or guidelines pooled it, 61 citations in OpenAlex.

  1. Clinical Practice Guidelines forAnnals of nuclear medicine · 2025
    Guideline
  2. Guideline
  3. Pooled it
  4. Metabolic Imaging and Molecular Signatures Reveal Metabolic Phenotypes in Recurrent Glioblastoma.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2026
    Article
  5. Article
  6. Review
  7. Article
  8. Physiological biodistribution ofFrontiers in nuclear medicine · 2026
    Article
  9. Potential impact of [Radiation oncology (London, England) · 2025
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. A comparison study of dynamic [Journal of cancer research and clinical oncology · 2024
    Article
  16. EJNMMI reports · 2024
    Article
  17. Diagnostic accuracy of anti-3-[European journal of nuclear medicine and molecular imaging · 2024
    Article
  18. Diagnostic Accuracy of PET withDiagnostics (Basel, Switzerland) · 2023
    Review
  19. Journal of neuro-oncology · 2023
    Article
  20. Glioblastoma PET/MRI: kinetic investigation of [European journal of nuclear medicine and molecular imaging · 2023
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 3 countries.

Laure MichaudMolecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 77, New York, NY, 10065, USA. michaudstudnialaure@gmail.com.ORCID 0000-0002-0234-2309
B J BeattieDepartment of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
T AkhurstPeter MacCallum Cancer Centre, Victoria, Australia.
M DunphyMolecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 77, New York, NY, 10065, USA.
P ZanzonicoDepartment of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
R FinnMolecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 77, New York, NY, 10065, USA.
A MauguenDepartment of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
H SchöderMolecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 77, New York, NY, 10065, USA.
W A WeberMolecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 77, New York, NY, 10065, USA.
A B LassmanDepartment of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
R BlasbergDepartment of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Memorial Sloan Kettering Cancer Center · USPeter MacCallum Cancer Centre · AU

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

purposeThe aim of our study was to investigate the efficacy of

methodsTwenty-seven patients with recurrent or progressive primary brain tumor (based on clinical and MRI/CT data) were studied using dynamic

results

conclusionTumor uptake of

Indexed as

Brain NeoplasmsCyclobutanesCarboxylic AcidsHumansNeoplasm Recurrence, LocalPositron-Emission TomographyRadiopharmaceuticalsCarboxylic AcidsCyclobutanesfluciclovine F-18Radiopharmaceuticals11C-methionine18F-FACBC18F-FluciclovineGliomaPET

Identifiers

PMID31418054
PMCPMC7188736
OpenAlexW2967147959

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.